Relmada Therapeutics (RLMD) Return on Capital Employed Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,478.00 |
| Dec 31, 2025 | -6,743.00 |
| Sep 30, 2025 | -41,363.00 |
| Jun 30, 2025 | -33,781.00 |
| Mar 31, 2025 | -22,816.00 |
| Dec 31, 2024 | -17,658.00 |
| Jun 30, 2024 | 20,053.00 |
| Mar 31, 2024 | 123,104.00 |
| Dec 31, 2023 | 164,329.00 |
| Sep 30, 2023 | -26,194.00 |
| Mar 31, 2023 | 442,275.00 |
| Dec 31, 2022 | 32,584.00 |
| Sep 30, 2022 | 78,493.00 |
| Jun 30, 2022 | 25,981.00 |
| Mar 31, 2022 | 14,743.00 |
| Dec 31, 2021 | 7,056.00 |
| Sep 30, 2021 | 5,586.00 |
| Jun 30, 2021 | 9,929.00 |
| Mar 31, 2021 | 6,826.00 |
| Dec 31, 2020 | 8,484.00 |
| Sep 30, 2020 | 7,594.00 |
| Jun 30, 2020 | 13,386.00 |
| Mar 31, 2020 | 48,319.00 |
| Dec 31, 2019 | 94,960.00 |